STOCK TITAN

Trinity Biotech plc (TRIB) Net Income by Year

TRIB

Trinity Biotech plc reported $1.9M in net income in fiscal year 2025. This represents an increase of 106.1% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Trinity Biotech plc has filed alongside them.

FY2025 annual
Net Income $1.9M
YoY +106.1%
10Y CAGR -21.7%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Apr 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TRIB Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Net Income$1.9M+106.1%-$31.2M+15.3%-$36.9M+15.4%-$43.6M-2256.0%-$1.9M+69.2%-$6.0M+79.3%-$29.0M-28.0%-$22.7M+41.4%-$38.7M-0.2%-$38.6M-273.9%$22.2M

TRIB Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-KQ1'2510-QQ3'2410-KQ3'2310-KQ1'2310-QQ3'2210-KQ3'2110-KQ3'2010-KQ3'1910-KQ1'1910-QQ4'1810-QQ3'1810-K
Net IncomeN/AN/AN/AN/AN/AN/AN/AN/AN/A$594K-34.1%N/AN/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Trinity Biotech plc financials

Frequently Asked Questions

What was Trinity Biotech plc's net income in fiscal year 2025?

Trinity Biotech plc reported $1.9M in net income in fiscal year 2025.

How fast is Trinity Biotech plc's net income growing?

Trinity Biotech plc (TRIB) net income rose by 106.1% year over year, from -$31.2M to $1.9M in fiscal year 2025.

How has Trinity Biotech plc's net income changed over the years?

Across the 11 fiscal years this page covers, Trinity Biotech plc (TRIB) net income went from $22.2M in fiscal year 2015 to $1.9M in fiscal year 2025.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Trinity Biotech plc (TRIB) reported on that line in every period on record.